HIM
HAE icon

Hermes Investment Management’s Haemonetics HAE Stock Holding History

Hermes Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-668,586
Closed -$30M – 229
2017
Q3 		$30M Sell
668,586
-20,525
-3% -$853K 0.45% 75
2017
Q2 		$27.2M Sell
689,111
-79,622
-10% -$3.27M 0.44% 88
2017
Q1 		$31.2M Buy
768,733
+9,683
+1% +$378K 0.5% 79
2016
Q4 		$30.5M Buy
759,050
+87,514
+13% +$3.3M 0.52% 74
2016
Q3 		$24.3M Buy
671,536
+44,912
+7% +$1.54M 0.41% 88
2016
Q2 		$18.2M Buy
626,624
+111,029
+22% +$3.36M 0.37% 99
2016
Q1 		$18.2M Sell
515,595
-109,003
-17% -$3.52M 0.38% 104
2015
Q4 		$20.1M Buy
624,598
+23,171
+4% +$752K 0.46% 91
2015
Q3 		$19.4M Sell
601,427
-4,810
-0.8% -$181K 0.5% 92
2015
Q2 		$25.1M Buy
606,237
+11,355
+2% +$479K 0.56% 85
2015
Q1 		$26.7M Buy
594,882
+71,474
+14% +$2.99M 0.62% 77
2014
Q4 		$19.6M Sell
523,408
-112,909
-18% -$4.14M 0.5% 89
2014
Q3 		$22.2M Buy
636,317
+11,068
+2% +$395K 0.57% 81
2014
Q2 		$22.1M Sell
625,249
-102,874
-14% -$3.44M 0.61% 82
2014
Q1 		$23.7M Sell
728,123
-6,850
-0.9% -$262K 0.75% 69
2013
Q4 		$31M Buy
734,973
+665,959
+965% +$27.4M 0.94% 52
2013
Q3 		$2.75M Hold
69,014
– – 0.09% 102
2013
Q2 		$2.85M Buy
+69,014
New +$2.79M 0.11% 108

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hermes Investment Management's HAE Position: Q4 2017 in Review

Hermes Investment Management sold out of Haemonetics (HAE) in Q4 2017, closing a stake of 668,586 shares — an estimated $30M sold.

Hermes Investment Management first reported a position in HAE in Q2 2013 and held it in 18 quarters. The position peaked at $31.2M in Q1 2017. 246 funds tracked by Wall St. Rank hold HAE as of Q4 2017.

  • Hermes Investment Management reported no remaining Haemonetics position as of Q4 2017 after selling out during the quarter.
  • Hermes Investment Management sold 668,586 Haemonetics shares in Q4 2017, an estimated $30M.
  • Hermes Investment Management first reported a position in Haemonetics in Q2 2013 and held it in 18 quarters.
  • Hermes Investment Management's Haemonetics position peaked at $31.2M in Q1 2017.
  • 246 funds tracked by Wall St. Rank held Haemonetics as of Q4 2017.

Based on Hermes Investment Management's 13F filing for Q4 2017, filed 24 Jan 2018.